Search

Author/Creator Henke, Michael

1. 231: Clinical Outcome after Multicenter, Open-Label Phase II Trial on Post-Surgery Chemoradiation in Combination with Cetuximab in Squamous Cell Carcinoma of the Head and Neck with High-Risk of Locoregional Recurrence. (September 2016)

Authors:
Boelke, Edwin; Matuschek, Christiane; Schipper, Joerg; Budach, Volker; Belka, Claus; Debus, Juergen; Wendt, Thomas; Stuschke, Martin; Wenz, Frederick; Henke, Michael; Budach, Wilfried
Journal:
Radiotherapy and oncology
Issue:
Volume 120(2016)Supplement 1
Page Start:
S84
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. An attention-based view of supply disruption risk management: balancing biased attentional processing for improved resilience in the COVID-19 context. Issue 13 (1st November 2021)

Authors:
Lorentz, Harri; Laari, Sini; Meehan, Joanne; Eßig, Michael; Henke, Michael
Journal:
International journal of operations & production management
Issue:
Volume 41:Issue 13(2021)
Page Start:
152
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial. Issue 2 (February 2015)

Authors:
Mesía, Ricard; Henke, Michael; Fortin, Andre; Minn, Heikki; Yunes Ancona, Alejandro Cesar; Cmelak, Anthony; Markowitz, Avi B; Hotte, Sebastien J; Singh, Simron; Chan, Anthony T C; Merlano, Marco C; Skladowski, Krzysztof; Zhang, Alicia; Oliner, Kelly S; VanderWalde, Ari; Giralt, Jordi
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
208
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial. Issue 2 (February 2015)

Authors:
Mesía, Ricard; Henke, Michael; Fortin, Andre; Minn, Heikki; Yunes Ancona, Alejandro Cesar; Cmelak, Anthony; Markowitz, Avi B; Hotte, Sebastien J; Singh, Simron; Chan, Anthony T C; Merlano, Marco C; Skladowski, Krzysztof; Zhang, Alicia; Oliner, Kelly S; VanderWalde, Ari; Giralt, Jordi
Journal:
Lancet oncology
Issue:
Volume 16:Issue 2(2015:Feb.)
Page Start:
208
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗